1. Home
  2. UNB vs MXCT Comparison

UNB vs MXCT Comparison

Compare UNB & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.76

Market Cap

121.6M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.31

Market Cap

136.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
MXCT
Founded
1891
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
136.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
UNB
MXCT
Price
$23.76
$1.31
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
5.8K
821.1K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
5.76%
N/A
EPS Growth
25.52
N/A
EPS
1.25
N/A
Revenue
N/A
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
$19.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.65
$0.64
52 Week High
$26.54
$1.86

Technical Indicators

Market Signals
Indicator
UNB
MXCT
Relative Strength Index (RSI) 45.43 57.66
Support Level $23.75 $1.19
Resistance Level $24.56 $1.54
Average True Range (ATR) 0.40 0.09
MACD -0.02 0.01
Stochastic Oscillator 30.00 52.38

Price Performance

Historical Comparison
UNB
MXCT

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: